Activated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring-Reference-Cited by-同舟云学术

Activated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring

Published:2013-04-01 Issue:4 Volume:139 Page:450-456
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Takemoto Clifford M.¹,Streiff Michael B.²,Shermock Kenneth M.²³,Kraus Peggy S.³,Chen Junnan⁴,Jani Jayesh⁴,Kickler Thomas²⁴

Affiliation:

1. Department of Pediatric Hematology, Johns Hopkins University School of Medicine, Baltimore, MD

2. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

3. Department of Pharmacy, Johns Hopkins University School of Medicine, Baltimore, MD

4. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/139/4/450/24993950/ajcpath139-0450.pdf

Reference17 articles.

1. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time;Basu;N Engl J Med,1972

2. The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays;Kitchen;Thromb Haemost,1996

3. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy;Olson;Arch Pathol Lab Med,1998

4. Antifactor Xa activity measured with amidolytic methods;Odegard;Haemostasis,1976

5. Comparative performance of three anti–factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous unfractionated heparin;Lehman;Am J Clin Pathol,2006

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality;Seminars in Thrombosis and Hemostasis;2024-08-27

2. Early thrombus detection in the extracorporeal membrane oxygenation circuit by noninvasive real-time ultrasonic sensors;Scientific Reports;2024-05-07

3. Early Thrombus Detection in the Extracorporeal Membrane Oxygenation Circuit by Noninvasive Real-time Ultrasonic Sensors;2024-02-06

4. Pharmacodynamic monitoring as an integral part of therapeutic drug monitoring;Therapeutic Drug Monitoring;2024

5. Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis;Journal of Thrombosis and Haemostasis;2023-12